Yu Liu

Yu Liu

Auto-generated profile, based on publicly available information

Yu Liu

The Affiliated Hospital of Stomatology School of Stomatology Zhejiang University School of Medicine and Key Laboratory of Oral Biomedical Research of Zhejiang Province Hangzhou Zhejiang China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2024 in International Journal of Oral Science
Verified
Journal Article
Open access
PDF file
MSMouyuan Sun
Mouyuan Sun
NZNing Zhan
Ning Zhan
ZYZhan Yang
Zhan Yang
XZXiaoting Zhang
Xiaoting Zhang
JZJingyu Zhang
Jingyu Zhang
HWHuiming Wang
Huiming Wang
The development, progression, and curative efficacy of head and neck squamous cell carcinoma (HNSCC) are influenced by complex interactions between epithelial and immune cells. Nevertheless, the specific changes in the nature of these interactions and their underlying molecular mechanisms in HNSCC are not yet fully understood. Cuproptosis, a form of programmed cell death that is dependent on copper, has been implicated in cancer pathogenesis. However, the understanding of cuproptosis in the context of HNSCC remains limited. In this study, we have discovered that cuproptosis-related long non-coding RNAs (CRLs) known as JPX play a role in promoting the expression of the oncogene urokinase-type plasminogen activator (PLAU) by competitively binding to miR-193b-3p in HNSCC. The increased activity of the JPX/miR-193b-3p/PLAU axis in malignant epithelial cells leads to enhanced cell proliferation, migration, and invasion in HNSCC. Moreover, the overexpression of PLAU in tumor epithelial cells facilitates its interaction with the receptor PLAUR, predominantly expressed on macrophages, thereby influencing the abnormal epithelial–immune interactome in HNSCC. Notably, the JPX inhibitor Axitinib and the PLAU inhibitor Palbociclib may not only exert their effects on the JPX/miR-193b-3p/PLAU axis that impacts the malignant tumor behaviors and the epithelial–immune cell interactions but also exhibit synergistic effects in terms of suppressing tumor cell growth and arresting cell cycle by targeting epidermal growth factor receptor (EGFR) and cyclin-dependent kinase (CDK4/6) for the treatment of HNSCC.

5 November 2023 in Infection
Verified
Journal Article
Open access
PDF file
YLYiting Lou
Yiting Lou
ZSZheyuan Sun
Zheyuan Sun
HMHaiying Ma
Haiying Ma
DCDanna Cao
Danna Cao
MSMouyuan Sun
Mouyuan Sun
HWHuiming Wang
Huiming Wang
Purpose The prevalence of odontogenic infections remains one of the highest in the world. If untreated, odontogenic infections can break through the limitation, disseminate to other organs or spaces, and cause high mortality rates. However, it is still difficult to rapidly target limited or disseminated infections in clinical practice. The type of disseminated odontogenic infections and the responsible bacteria have not been described in detail. Methods Search databases (e.g., PubMed, MEDLINE, Web of Science, Embase) for reports published from 2018.1 to 2022.9. Use search strategies: (“odontogenic infections” OR “pulpitis” OR “periapical lesions” OR “periodontal diseases”) AND (“disseminated infections” OR “complication”). Results Fourteen different types of disseminated odontogenic infections, most of which are polymicrobial infections, can spread through the body either direct or through hematogenous diffusion. Multiple microbial infections can be more invasive in the transmission of infection. Secondary infections are commonly associated with bacteria like Fusobacterium spp., Streptococcus spp., Peptostreptococcus spp., Prevotella spp., and Staphylococcus spp. Antibiotics with broad-spectrum activity are fundamental as first-line antimicrobial agents based on the microorganisms isolated from disseminated infections. Conclusion This review elaborates on the epidemiology, microorganisms, risk factors, and dissemination routes, and provides evidence-based opinions on the diagnosis, multidisciplinary management, and prevention of odontogenic infections for dentists and clinicians.

16 May 2022 in Clinical Implant Dentistry and Related Research
Verified
Journal Article
Closed access
JSJue Shi
Jue Shi
JZJinhan Zhou
Jinhan Zhou
CLChuanxia Liu
Chuanxia Liu
YLYu Liu
Yu Liu
MSMisi Si
Misi Si

22 December 2025 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
PDF file
JKJianlu Kong
Jianlu Kong
ZZZiyu Zhu
Ziyu Zhu
YHYijie Hu
Yijie Hu
SZSiyi Zhou
Siyi Zhou
TGTianyi Gu
Tianyi Gu
YLYu Liu
Yu Liu
Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumors worldwide. This necessitates the development of innovative drugs with high e

22 May 2026 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
YYYemu Yang
Yemu Yang
ZZZiyu Zhu
Ziyu Zhu
CZChuhan Zhang
Chuhan Zhang
DHDesheng Hong
Desheng Hong
CXChengyu Xie
Chengyu Xie
YLYu Liu
Yu Liu

22 August 2026 in Small
Verified
Journal Article
Closed access
ZZZiyu Zhu
Ziyu Zhu
SZSiyi Zhou
Siyi Zhou
TGTianyi Gu
Tianyi Gu
YLYu Liu
Yu Liu
KXKuoran Xing
Kuoran Xing
MYMengfei Yu
Mengfei Yu